Anticonvulsant agent 5 (Compound 5c) exhibits high affinity for GABA A receptors and NaV 1.3 receptors. Anticonvulsant agent 5 shows anticonvulsant efficacy in mice psychomotor epilepsy test with an ED 50 of 107 mg/kg. Anticonvulsant agent 5 exhibits neuroprotective activity against Kainic acid with an IC 50 of 113 μM. Anticonvulsant agent 5 is blood-brain barrier (BBB) penetrable.